Compound Monograph
Ethyl Vanillin
Ethyl vanillin (3-ethoxy-4-hydroxybenzaldehyde) is the synthetic ethoxy homologue of vanillin — a major commercial flavouring roughly three times more potent than vanillin, but one that does NOT occur in the vanilla bean. Its presence in a 'vanilla' product is a marker of synthetic or adulterated flavouring, not of real vanilla. Its health literature is thin and entirely preclinical: it raises plasma antioxidant capacity in mice and behaves as a strong antioxidant in some assays, with scattered antimicrobial, neuroprotective and sensory-irritant (TRPA1) signals.
Sources · 2
Where Does It Come From?
Ethyl Vanillin is a synthetic phenolic aldehyde (synthetic vanillin homologue), found in Chocolate, confectionery and baked goods and Synthetic vanilla flavourings / imitation vanilla. It is well tolerated orally (low toxicity).
Concentration
Content by Source
Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.
Ethyl Vanillin at a Glance
Ethyl vanillin, or 3-ethoxy-4-hydroxybenzaldehyde, is the synthetic ethoxy homologue of vanillin — the same phenolic aldehyde with an ethoxy (–OC₂H₅) group in place of vanillin’s methoxy (–OCH₃). That one-carbon change makes it roughly three times more potent as a flavour, which is why it is one of the world’s major commercial flavourings, sold as “ethylvanillin” or under the trade name bourbonal 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
The single most important fact about this molecule is what it is not: ethyl vanillin does not occur in the vanilla bean, or in any natural vanilla source. It is a made molecule, and its detection in a product labelled “vanilla” is a standard marker of synthetic or adulterated flavouring — the analytical fingerprint that a “vanilla” flavour was built in a factory rather than extracted from a cured pod. The vanilla monograph flags exactly this concern about “synthetic vanillin and other adulterants”; ethyl vanillin is the clearest chemical signature of that adulteration.
Its pharmacology is thin and honest to state plainly: this is primarily a flavour chemical, and its “health” literature is a small preclinical scatter. The best-supported thread is antioxidant — it raised plasma antioxidant capacity when fed to mice and behaves strongly in some radical assays 1,
The Synthetic Homologue of Vanillin
Ethyl vanillin is best understood as vanillin with a bigger alkoxy group. Both molecules share the same 4-hydroxybenzaldehyde core carrying an ortho-alkoxy substituent; the only difference is that vanillin’s is a methoxy (–OCH₃) and ethyl vanillin’s is an ethoxy (–OC₂H₅). That extra methylene does two things: it makes the molecule more lipophilic, and — for reasons of receptor and olfactory binding — it makes it a markedly stronger flavourant, commonly quoted as ~3× the flavour intensity of vanillin at equal weight 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
Because the difference is so small structurally, ethyl vanillin sits alongside vanilla’s own C6-C1 phenolics in most comparative studies — vanillin, vanillic acid and vanillyl alcohol — and is routinely tested next to them. In those panels ethyl vanillin tends to track vanillin’s behaviour rather than the reduced or oxidised members: in the ORAC assay, for instance, ethyl vanillin and vanillin out-perform vanillyl alcohol and vanillic acid, the reverse of the ranking in hydrogen-donation assays 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study →. So structurally and functionally it is vanillin’s near-twin — with the crucial difference that vanillin is a genuine natural constituent of vanilla and ethyl vanillin is not.
An Adulteration Marker, Not a Vanilla Constituent
This section is the honest core of the page. Real vanilla flavour is an expensive, agriculturally limited product, and the flavour industry has long substituted or stretched it with cheaper synthetics. Vanillin can be natural (from the bean) or synthetic (from guaiacol, lignin or ferulic acid), so vanillin alone does not reveal a product’s origin. Ethyl vanillin is different: it has no natural source in vanilla at all, so its presence is unambiguous evidence that a “vanilla” flavour contains a synthetic component 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
For that reason, ethyl vanillin is one of the target analytes in authenticity testing of vanilla extracts and “vanilla”-labelled foods — its detection, or an off-natural ratio of vanilla marker compounds, flags imitation or adulterated product. This is the same concern the vanilla page raises when it warns readers about “synthetic vanillin and other adulterants.” None of this makes ethyl vanillin unsafe as a food additive — it is permitted and widely used — but it does mean that a page about ethyl vanillin is a page about a flavour chemical and an adulteration marker, not about a plant medicine.
What It's Used For
Ethyl vanillin’s pharmacology is a thin preclinical scatter built around one reasonably characterised property (antioxidant) and a few single studies. There is no human efficacy data, and the molecule’s reason for existing is flavour, not therapy.
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row rests on isolate cell/animal/assay work — most on a single study — with no human trials, so scores stay low by design; read the per-row basis.
The best-characterised property, and the only one with an in-vivo data point. When ethyl vanillin was administered orally to mice, it raised antioxidant activity in the plasma more effectively than vanillin did, with the dose showing up as increased circulating ethyl vanillic acid (its oxidised metabolite) 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study →.
In vitro the picture is assay-dependent, exactly as for vanillin: in the ORAC assay ethyl vanillin and vanillin are the strong performers, out-scoring vanillyl alcohol and vanillic acid, whereas in the DPPH and galvinoxyl (hydrogen-donation) assays ethyl vanillin is essentially inert because — like vanillin — it scavenges through a self-dimerisation route rather than donating a hydrogen atom 1,
The authors argue the antioxidant activity “might be more beneficial than has been thought” for daily health, but the claim rests on assay chemistry plus one rodent plasma measurement 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study →.
Gap: in-vitro results that diverge sharply by assay method, and a single rodent plasma-capacity study; no human antioxidant outcome, and raised plasma “antioxidant capacity” is a biomarker, not a health outcome 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study →.
The activity most consistent with ethyl vanillin’s real-world use. Tested against Cronobacter species (opportunistic foodborne pathogens) alongside vanillin and vanillic acid, ethyl vanillin was the most potent of the three, with a minimum inhibitory concentration of about 2 mg/mL (vs 3 mg/mL for vanillin and >8 mg/mL for vanillic acid); activity was pH- and temperature-dependent, the compounds damaged bacterial cell membranes, and they sharply reduced the bacteria’s heat resistance 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
Separate food-science work has incorporated ethyl vanillin into antibacterial packaging films, consistent with a genuine but modest preservative role 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
Gap: bacteriostatic/bactericidal activity at milligram-per-millilitre concentrations (a food-preservation regime, not a systemic antibiotic one); this is food-technology data, not evidence of any clinical anti-infective use 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
One cell-model study, riding on the antioxidant mechanism. In PC12 cells exposed to aggregated amyloid-β (Aβ1-42) — a neurotoxicity model relevant to Alzheimer’s disease — ethyl vanillin (10-100 µM) restrained the loss of cell viability and the induction of apoptosis, lowered reactive oxygen species and malondialdehyde (lipid-peroxidation) levels, and helped restore antioxidative-enzyme activity, protecting the cells by relieving oxidative stress 5Reference 5Protective effect of ethyl vanillin against Aβ-induced neurotoxicity in PC12 cells via the reduction of oxidative stress and apoptosisView study →.
Gap: a single in-vitro isolate study in one cell line, with no in-vivo or human data and open questions about brain exposure for a small synthetic phenol 5Reference 5Protective effect of ethyl vanillin against Aβ-induced neurotoxicity in PC12 cells via the reduction of oxidative stress and apoptosisView study →.
A mechanistic contrast worth stating precisely. Where the reduced vanilla phenol vanillyl alcohol is a weak agonist of the capsaicin receptor TRPV1, ethyl vanillin instead activates TRPA1 — the “wasabi/mustard-oil” irritant channel. In calcium imaging, patch-clamp and TRPA1-knockout studies, ethyl vanillin behaved as a TRPA1 agonist, but one requiring intracellular oxidation to act, and it engaged the channel by a route distinct from the classic agonist allyl isothiocyanate 4Reference 4Ethyl vanillin activates TRPA1View study →.
This is sensory pharmacology (it helps explain how the flavour molecule is detected by irritant-sensing neurons), not a therapeutic effect.
Gap: an in-vitro receptor study establishing agonism and its oxidation-dependence only; no physiological or therapeutic consequence is demonstrated, and TRPA1 activation is an irritant/sensory action rather than a benefit 4Reference 4Ethyl vanillin activates TRPA1View study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| ORAC / peroxyl-radical scavenging | strong antioxidant capacity (out-performs vanillyl alcohol / vanillic acid) | antioxidant |
| Plasma antioxidant capacity (oral, mouse) | ↑ circulating antioxidant activity — greater than vanillin in vivo | antioxidant |
| DPPH / galvinoxyl (hydrogen donation) | near-inert — scavenges via self-dimerisation, not H-atom donation | antioxidant (assay contrast) |
| ROS / lipid peroxidation / apoptosis (PC12, Aβ) | ↓ ROS, ↓ MDA, ↓ apoptosis → neuronal protection | neuroprotective |
| Bacterial cell membrane (Cronobacter) | membrane damage; ↓ heat resistance; bacteriostatic/-cidal (MIC ~2 mg/mL) | antimicrobial |
| TRPA1 ion channel (oxidation-dependent) | agonism — sensory/irritant activation | TRPA1 / sensory activity |
The load-bearing thread is antioxidant / free-radical scavenging — the one property with both in-vitro and in-vivo (rodent plasma) support, and the mechanism the neuroprotection study leans on. The antimicrobial action is a real food-preservation property at high concentrations; the TRPA1 action is sensory, not therapeutic.
Pharmacokinetics
Ethyl vanillin’s human pharmacokinetics are essentially uncharacterised — no Cmax, half-life or oral-bioavailability figures are established for the isolate. What is known is fragmentary and animal-derived: oral dosing in mice produced a measurable rise in ethyl vanillic acid in blood, indicating it is absorbed and oxidised (aldehyde → acid) much as vanillin is metabolised to vanillic acid 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study →. By analogy to vanillin it is expected to be a small, moderately lipophilic phenolic aldehyde cleared rapidly by oxidation and glucuronide/sulfate conjugation. The cell and preservation studies above use direct exposure at defined concentrations 3,
Clinical Trials
There are no controlled human efficacy trials of ethyl vanillin. It has never been studied as a therapeutic; the entire evidence base is in-vitro, food-science and rodent work, and human exposure is dietary — as a flavouring.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| —(none of the isolate) | — | — | Antioxidant, antimicrobial/food-preservation, neuroprotective (cell), TRPA1 sensory |
Last checked: July 2026.
Not a Plant Constituent
Where the other vanilla phenol pages have a “role in the plant,” ethyl vanillin has none — and saying so is the point. It is a fully synthetic molecule with no known natural occurrence in vanilla or, in any meaningful quantity, in the diet except as a deliberately added flavouring 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →. Everything here is therefore either isolate chemistry (radical assays, ORAC), isolate biology (bacterial cultures, PC12 cells, TRPA1-expressing neurons), or rodent dosing 1,
That is also why the comparison that matters most is with its natural twin, vanillin. In head-to-head panels the two behave similarly — often with ethyl vanillin slightly ahead (stronger antimicrobial potency, greater in-vivo plasma antioxidant rise) — but vanillin carries the broader researched pharmacology and, unlike ethyl vanillin, is a genuine constituent of the cured bean. For the vanilla-phenol redox family and the vanilloid head-group story, see the vanillin, vanillic acid and vanillyl alcohol pages.
Discovery & Synthesis
Ethyl vanillin was developed as a more potent synthetic substitute for vanillin, and it has been a commercial flavouring for over a century — long enough to acquire the trade names bourbonal and ethyl protal. It is manufactured wholly by chemical synthesis (classically from catechol/guaiacol-type feedstocks, ethylated to install the ethoxy group and functionalised to the aldehyde), never by extraction — there is no natural pool to extract it from 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study →.
Its identity as a made molecule is the throughline: it exists because the market wanted a cheaper, stronger vanilla note than either natural extract or synthetic vanillin could supply, and its very artificiality is what makes it useful as an authenticity marker for detecting adulterated “vanilla” products.
Patents: not researched.
Toxicity & Safety
Ethyl vanillin carries a low flag. It is a long-established permitted food flavouring — evaluated by JECFA and holding FEMA GRAS status — used for decades in chocolate, confectionery, baked goods and imitation-vanilla products at flavouring levels, and structurally very close to vanillin, which it is metabolised like (oxidation to ethyl vanillic acid, then conjugation) 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study →. In the preclinical literature it appears as a protective agent — antioxidant, antimicrobial, neuroprotective — rather than a toxicant 1,
The honest limits are the usual ones for a molecule with no human safety trials of the isolate as anything but a flavouring: dedicated repeat-dose, genotoxicity and reproductive packages beyond the flavouring evaluations are not detailed here, and there are no human drug-interaction studies. One point specific to this molecule: it is a TRPA1 agonist, the irritant-sensing channel 4Reference 4Ethyl vanillin activates TRPA1View study →, so at non-culinary, concentrated exposures it is a plausible sensory irritant — but nothing at dietary, flavouring levels suggests concern. As with vanilla and vanillin generally, allergy to vanilla-family phenols is documented and carries over in principle.
- A long-permitted food flavouring. JECFA-evaluated and FEMA GRAS, used for decades at flavouring levels; metabolised like vanillin and not classed as a carcinogen, mutagen or reproductive toxicant.
- Preclinical studies use it as a protectant. Antioxidant, antimicrobial and neuroprotective effects — not toxicity — in the assay, bacterial and cell literature.
- Safety rests on flavouring and preclinical data. No human therapeutic trials, and no detailed repeat-dose/genotoxicity package for the isolate beyond its flavouring evaluations.
- A sensory irritant at concentrated exposure. It activates the TRPA1 irritant channel; a theoretical, unquantified consideration at non-culinary concentrations, not a concern at food levels.
Dosage
There is no established or recommended human dose for isolated ethyl vanillin — it is a flavouring, not a supplement, and should not be self-dosed for any health purpose. The figures below are preclinical research values, not convertible to human use:
| Application | Form / route (research) | Level studied |
|---|---|---|
| Antioxidant (in vivo) | Ethyl vanillin, mouse (oral) | raised plasma antioxidant activity 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivoView study → |
| Antioxidant (in vitro) | Ethyl vanillin, assays | ORAC / DPPH / galvinoxyl assay concentrations 1, |
| Antimicrobial | Ethyl vanillin, bacterial culture | MIC ~2 mg/mL vs Cronobacter 3Reference 3Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter speciesView study → |
| Neuroprotective | Ethyl vanillin, PC12 cells | 10-100 µM (amyloid-β model) 5Reference 5Protective effect of ethyl vanillin against Aβ-induced neurotoxicity in PC12 cells via the reduction of oxidative stress and apoptosisView study → |
Human exposure is dietary and low — flavouring-level amounts permitted for food use — and where the studied route was direct cell/bacterial exposure, no oral equivalent is meaningful. These are research values, not a personal recommendation.
References
- Tai A, Sawano T, Yazama F (2011). Antioxidant properties of ethyl vanillin in vitro and in vivo. Bioscience, Biotechnology, and Biochemistry, 75(12):2346-50. https://pubmed.ncbi.nlm.nih.gov/22146718/
- Tai A, Sawano T, Yazama F, Ito H (2011). Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays. Biochimica et Biophysica Acta, 1810(2):170-177. https://pubmed.ncbi.nlm.nih.gov/21095222/
- Yemiş GP, Pagotto F, Bach S, Delaquis P (2011). Effect of vanillin, ethyl vanillin, and vanillic acid on the growth and heat resistance of Cronobacter species. Journal of Food Protection, 74(12):2062-2069. https://pubmed.ncbi.nlm.nih.gov/22186046/
- Wu SW, Fowler DK, Shaffer FJ, Lindberg JEM, Peters JH (2017). Ethyl vanillin activates TRPA1. Journal of Pharmacology and Experimental Therapeutics, 362(3):368-377. https://pubmed.ncbi.nlm.nih.gov/28620120/
- Zhong L, Tong Y, Chuan J, Bai L, Shi J, Zhu Y (2019). Protective effect of ethyl vanillin against Aβ-induced neurotoxicity in PC12 cells via the reduction of oxidative stress and apoptosis. Experimental and Therapeutic Medicine, 17(4):2666-2674. https://pubmed.ncbi.nlm.nih.gov/30930969/
